Inventor

KAUFMAN MICHAEL D

US46 patents

⚠️ This page may combine multiple inventors who share the name “KAUFMAN MICHAEL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KAUFMAN MICHAEL D

DECIPHERA PHARMACEUTICALS LLC

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

Amorphous kinase inhibitor formulations and methods of use thereof

N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities

N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

RAF inhibitor compounds

Raf inhibitor compounds

Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities

Methods for inhibiting tie-2 kinase useful in the treatment of cancer

1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities

Amorphous kinase inhibitor formulations and methods of use thereof

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

Amorphous kinase inhibitor formulations and methods of use thereof

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

Kinase inhibitors useful for the treatment of proliferative diseases

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

Solid state forms of a kinase inhibitor

CSF-1R inhibitors and methods of use thereof

FLYNN DANIEL L

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

N-acyl ureas exhibiting anti-cancer and anti-proliferative activities

Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases

DECIPHERA PHARMACEUTICALS INC

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

LILLY CO ELI

Raf inhibitor compounds

UNIV PENNSYLVANIA

Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof